Mild cognitive impairment: an overview. (Q31143111)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18204414%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

review article

1 reference

title

Mild cognitive impairment: an overview (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18204414%20AND%20SRC:MED&resulttype=core&format=json

mild cognitive impairment

1 January 2020

main subject

1 reference

inferred from title

cognitive dysfunction

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18204414%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

1

Ronald C Petersen

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18204414%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

publication date

1 January 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18204414%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18204414%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

volume

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18204414%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

page(s)

45-53

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18204414%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18204414%20AND%20SRC:MED&resulttype=core&format=json

Mild cognitive impairment should be considered for DSM-V.

1 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900016151

7 January 2021

Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memory-impaired individuals.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900016151

7 January 2021

Behavioral symptoms in mild cognitive impairment

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900016151

7 January 2021

Vitamin E and donepezil for the treatment of mild cognitive impairment

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900016151

7 January 2021

Mild cognitive impairment clinical trials

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900016151

7 January 2021

Neuropathologic features of amnestic mild cognitive impairment

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900016151

7 January 2021

Neuropathologic outcome of mild cognitive impairment following progression to clinical dementia.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900016151

7 January 2021

Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900016151

7 January 2021

Neuropathologic substrate of mild cognitive impairment.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900016151

7 January 2021

Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900016151

7 January 2021

Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900016151

7 January 2021

Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer disease

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900016151

7 January 2021

Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900016151

7 January 2021

Brain atrophy rates predict subsequent clinical conversion in normal elderly and amnestic MCI.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900016151

7 January 2021

Imaging of onset and progression of Alzheimer's disease with voxel-compression mapping of serial magnetic resonance images.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900016151

7 January 2021

Mortality in amnestic mild cognitive impairment: a prospective community study.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900016151

7 January 2021

A prospective study of the clinical utility of ApoE genotype in the prediction of outcome in patients with memory impairment

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900016151

7 January 2021

Mild cognitive impairment in different functional domains and incident Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900016151

7 January 2021

Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900016151

7 January 2021

The Clinical Dementia Rating (CDR): current version and scoring rules

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900016151

7 January 2021

Mild cognitive impairment as a diagnostic entity

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900016151

7 January 2021

Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900016151

7 January 2021

Predicting conversion to Alzheimer disease using standardized clinical information.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900016151

7 January 2021

Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900016151

7 January 2021

The Global Deterioration Scale for assessment of primary degenerative dementia

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900016151

7 January 2021

Aging-Associated Cognitive Decline

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900016151

7 January 2021

A randomized, double-blind, study of rofecoxib in patients with mild cognitive impairment

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900016151

7 January 2021

Differential cross-sectional and longitudinal impact of APOE genotype on hippocampal volumes in nondemented older adults

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900016151

7 January 2021

Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900016151

7 January 2021

Variations in case definition affect prevalence but not outcomes of mild cognitive impairment

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900016151

7 January 2021

Mild cognitive impairment: clinical characterization and outcome

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900016151

7 January 2021

Mild cognitive impairment in the elderly: predictors of dementia

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900016151

7 January 2021

The public health impact of Alzheimer's disease, 2000-2050: potential implication of treatment advances

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900016151

7 January 2021

Prevalence and severity of cognitive impairment with and without dementia in an elderly population.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900016151

7 January 2021

Mild cognitive impairment represents early-stage Alzheimer disease

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900016151

7 January 2021

Mild cognitive impairment--beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900016151

7 January 2021

Mild cognitive impairment, amnestic type: an epidemiologic study.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900016151

7 January 2021

Classification criteria for mild cognitive impairment: a population-based validation study

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900016151

7 January 2021

Incidence and outcome of mild cognitive impairment in a population-based prospective cohort.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900016151

7 January 2021

Mild cognitive impairment

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900016151

7 January 2021

Mild cognitive impairment: long-term course of four clinical subtypes

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900016151

7 January 2021

10.1017/S1092852900016151

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18204414%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

1 reference